🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of FT-2102 wh...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-08-27
Trial ID
NCT04013880
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
This phase I trial is studying the side effects and best dose of vorinostat...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00357708
Treatments Being Tested
The main aim of the study is to see if signs and symptoms of myelodysplasti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04985656
Treatments Being Tested
This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Status
Recruiting
Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Start Date
2024-01-01
Trial ID
NCT06429098
Treatments Being Tested
The purpose of this research study is to see if people whose Acute myeloid ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-11-07
Trial ID
NCT06511882
Treatments Being Tested
The goal of this clinical research study is to learn if combining Sprycel (...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-06-12
Trial ID
NCT01498445
Treatments Being Tested
This study is designed to examine blood levels of ASTX727, a fixed-dose com...
Status
Completed
Location
Roswell Park
Start Date
2018-11-08
Trial ID
NCT03813186
Treatments Being Tested
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580